grants_govRFA-DK-28-213
Open
The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
- Response deadline
- Mar 5, 2027 Due in 121 days
- Date posted
- Nov 3, 2026
- Source
- Open notice
Description
This Notice of Funding Opportunity (NOFO) invites new applications to participate in the Diseases of Gastrointestinal Interoception Consortium (DGIC). The overall objectives of this consortium are to: 1) identify the underlying mechanisms that link altered GI interception more directly to GI dysmotility and symptoms; 2) identify disease or response biomarkers that better assess pathophysiology or treatment efficacy; and 3) leverage state-of-the-art technologies to identify novel therapeutic targets that could be assessed in future clinical trials. This NOFO uses a cooperative agreement mechanism (U01) and runs in parallel with a companion NOFO ( RFA-DK-28-214) .
Classifications
- NAICS93.KRC
Documents (1)
- RFA-DK-28-213-Full-Announcement.htmltext/html;charset=UTF-8133 KBNot yet available
Contacts
Similar contracts
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)Due Feb 1, 2027
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)Due Mar 5, 2027
- Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)Due Mar 5, 2029
- NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)Due May 26, 2027
- Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)Due Jan 10, 2028
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)Due Feb 8, 2028